Insights On Partnering

  1. Use Case: A Patient-Centric Approach To Site Selection 1/27/2025

    Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease. 

  2. Expand Bandwidth With A Trusted Regulatory Writing Partner 9/18/2025

    Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.

  3. 5 Questions That Put Sponsors Back in Control of Bioanalysis Projects 12/9/2025

    Bioanalysis service quality significantly impacts project success. Don't settle for typical CRO claims; demand better technology, pricing transparency, and dedicated partnership.

  4. RTSM Software Isn't One-Size-Fits-All, Especially For Small Biotechs 5/13/2026

    Smaller biotech companies often have very different clinical trial needs than large pharmaceutical organizations, and that includes RTSM.

  5. Are Your Trial Payments Creating Hidden Compliance Risks? 7/13/2026

    Clear separation of reimbursements, stipends, and site payments helps reduce compliance risk, improve transparency, and support ethical compensation.

  6. Enhance Recruitment & Retention For Rare Kidney Disease Trials 8/10/2026

    Though the burdens of developing treatments for rare kidney diseases are high, data-driven recruitment strategies and experienced CRO teams will help ensure accessible trials with strong enrollment.

  7. Advanced Aseptic Filling Line: Vials, Syringes, And Cartridges 8/16/2025

    See how a cutting-edge, multi-purpose isolator line delivers high-speed, precision fill/finish. This flexible technology supports a diverse range injectable therapies.

  8. Coordinator Services For High-Volume Research Sites 4/30/2026

    Remove the administrative burden of travel and reimbursements from your site staff with a service providing takes over direct communication, travel inquiries, and administrative entries

  9. Unanticipated Roadblocks In Ovarian Cancer Drug Development 3/9/2026

    Enhance your Ovarian cancer trials by enabling community referral pipelines, aligning imaging with biomarker assessments, and selecting sites based on verifiable surgical capacity.

  10. The Hidden Cost Of Preferred Vendors 10/21/2025

    Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.